TKNO Stock Analysis: Buy, Sell, or Hold?
TKNO - Alpha Teknova, Inc. Common Stock
$4.89
-0.27 (-5.23%)
▼
5d:
+18.4%
30d:
+26.36%
90d:
+67.47%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When TKNO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: TKNO shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: TKNO shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: TKNO is currently trading at $4.89, which is considered slightly high relative to its 30-day fair value range of $3.98 to $5.12.
Technical Outlook: Technically, TKNO is in a strong uptrend. Immediate support is located at $3.89, while resistance sits at $5.78. Short-term momentum is weak, with the stock down 5.2% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.00 (+84.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TKNO is in a strong uptrend. Immediate support is located at $3.89, while resistance sits at $5.78. Short-term momentum is weak, with the stock down 5.2% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.00 (+84.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$3.98 -
$5.12
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.6%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.2%)
- BULLISH: Trading 84.0% below Wall St target ($9.00)
Trading Range Analysis
30-Day Trading Range
$3.98 -
$5.12
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$3.89
Resistance Level
$5.78
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-19.96
Wall Street Target
$9.00
(+84.0%)
Revenue Growth (YoY)
13.1%
Profit Margin
-41.1%
Share & Embed Analysis
Last updated: June 24, 2026 6:27 AM ET
Data refreshes hourly during market hours. Next update: 7:27 AM
Data refreshes hourly during market hours. Next update: 7:27 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TKNO showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Stephen Gunstream
BUY
26000 shares
2026-03-06
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$194 | 60 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 64 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 67 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 58 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 57 HOLD |
